=Subscribers Only
The High Cost of Small Cons
Small-business owners are often reluctant to spend time and money on due diligence when hiring employees or making deals. This, says former prosecutor Robert Silbering, is why they are some of the easiest marks for con men and embezzlers.

  VIDEO VIEWS

Retail Outlook
Will weakness in housing and rising energy prices mean consumers are running out of gas? We talk with a retail analyst and a consumer expert about the outlook for the holiday season

  SPECIAL REPORTS
Best Global Brands
These 100 brands are among the world's most recognized—and most valuable

Best Places to Launch a Career
We canvassed career-services directors, employers, and students to rank the best companies for recent graduates

BusinessWeek 50
Our picks of the top-performing companies from the S&P 500. Plus, regional rankings for Asia and Europe:
Asia's BusinessWeek 50
Europe's BusinessWeek 50

Customer Service Champs
Companies that excel at pleasing customers, based on J.D. Power & Associates customer satisfaction data and our own reader survey

Hot Growth 100
From young, upstart companies to those that have been around for centuries: Plus, regional rankings of top-performing small businesses in Asia and Europe:
Asia's Hot Growth 100
Europe's Hot Growth 100

Info Tech 100
Emerging-market cellular players, wireless phone and gear makers, and Web giants are this year's stars

World's Most Innovative Companies
Nurturing, creative cultures allow these companies to wow customers with innovative products and services

• More Special Reports

Microsoft Cuts the Chatter
While its decision to limit MSN's popular Internet chat rooms to paying customers has critics crying foul, it makes sense both legally and economically.

 Why Hillary Should Run
Hillary Rodham Clinton has repeatedly denied she will take a run at unseating George W. Bush in November, 2004. However, if the Democratic Party's only true star genuinely wants to be President, her time is now. By 2008, it may well be too late.

 Thalidomide's Surprising Act IV
Once hailed as a miracle cure, the drug became notorious for causing thousands of birth defects. Then it proved to be a relief for patients suffering from a rare immune disorder. Now, it shows promise as a cancer fighter, and its noxious side effects can be largely eliminated.

 Tourists Say Au Revoir to France
After a two-year boom, tourism is being clobbered, thanks to everything from a strong euro to international tensions to oil slicks and forest fires.

Insights from S&P
Keep abreast of the markets each day with our exclusive coverage from S&P analysts, regular market updates, and stock picks and pans.


  MARKET INFO
DJIA 0 0.00
S&P 500 0 0.00
Nasdaq 0 0.00

Portfolio Service Update

Stock Lookup

Enter name or ticker

 BW MALL   SPONSORED LINKS
Buy a link now!



Copyright 2003, Bloomberg L.P.
Terms of Use | Privacy Policy
Advertising | Special Sections | MarketPlace | Knowledge Centers
Bloomberg L.P.